Genitourinary Physician Investigator/Director

The START Center for Cancer Research (“START”) is the world’s largest early phase site network, fully dedicated to oncology clinical research. Throughout our history, START has provided hope to cancer patients in global community practices by offering access to cutting edge trials throughout the US and Europe. Today, with over 1,300 studies completed, and with research facilities in the United States and in Spain, Portugal, and Ireland, START’s mission is to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer and lead to its eventual cure. To date, over 43 therapies conducted at START locations have obtained FDA/EMA approval. Incredibly, while Academic Medical Centers (AMCs) conduct 80% of cancer trials, such trials reach only 20% of the patient population – leaving the majority of patients who are treated in community practices and hospitals without access to a clinical trial when their care journey calls for one. START serves the many – by bringing cancer trials to physicians and their patients in community hospitals and practices when hope is needed most.

Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. As an example, in San Antonio, where START was founded, START treated the first patient ever with Keytruda – the most effective cancer drug in medical history.

We are seeking a Genitourinary (GU) Physician Investigator (PI).

The Genitourinary (GU) Physician Investigator (PI) is a physician-scientist with demonstrated clinical research team leadership skills responsible for the overall preparation, conduct, and management of GU Oncology clinical trials including Phase 1 studies. This role will manage the development and execution of clinical trial protocols, contribute to data analysis, and maintain strong communication and alignment with industry sponsors while maintaining compliance with all regulatory requirements and institutional policies.

Essential Responsibilities

• Strong leadership skills to oversee early and late phase GU clinical trials by providing overarching medical direction and comprehensive medical reviews of protocols in conformance with the investigational plan and good clinical practice
• Work collaboratively across healthcare provider disciplines with urologic oncologists, radiation oncologists, nuclear medicine radiologists, pathologists and medical oncology physicians
• Provide medical and scientific feasibility of all new sponsor inquiries driving growth through strategic partnerships
• Lead and manage a matrix team responsible for the conduct of GU oncology trials
• Ensure the safety and well-being of all trial site participants are protected
• Ensure data collected at the study site is credible and accurate
• Ensure the ethical rights, integrity, and confidentiality of all participants at the trial site are protected
• Develop professional working relationships with Sponsors and Clinical Research Organizations involved in study conduct
• Provide expert guidance and support to clinical operations research staff and sponsor client
• Lead continuous quality improvement efforts for clinical research services, integrating best practices and fostering a culture of research excellence and multidisciplinary collaboration
• Develop and implement strategies to enhance patient recruitment and retention in clinical trials
• Strong collaborative skills working with START Co-Investigator physicians and across the START Network.
  
  

Required Education And Experience

• M.D. or equivalent
• Board Certified in Medical Oncology or Urology
• Qualified for relevant US State Medical Licensing
• Clinical trials experience with a strong interest in drug development and publications
• Ability to critically analyze clinical scientific data and literature
• Understanding of Good Clinical Practice (GCP) principles, safety and adverse event reporting, FDA regulations, and biomedical research ethics
• Passion for providing excellence of clinical care and for working in a collaborative / team-oriented environment
• Strong leadership skills with entrepreneurial mindset encompassing an aggressive approach to growth and expansion
  
  

Preferred Education And Experience

• Previous experience with industry sponsored clinical trials
• Excellent communication skills, with experience in publishing and presenting at scientific meetings
• Translational research experience and familiarity with early and late stage clinical trials
  
  

Travel Requirements

• Travel expectations of at least 15% of time.
  
  

Potential applicants should directly contact Mary Vidovich (Mary.Vidovich@startresearch.com) or Chris H. Takimoto, MD, PhD (chris.takimoto@startresearch.com) at START Research

More about The START Center for Cancer Research

Deeply rooted in community oncology centers globally, The START Center for Cancer Research provides access to specialized preclinical and early-phase clinical trials of novel anti-cancer agents. START clinical trial sites have conducted more than a thousand early-phase clinical trials, including for 43 therapies that were approved by the FDA. START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. Learn more at STARTresearch.com.

Ready to be part of a team changing the future of cancer treatment?

Join us in our mission to conquer cancer, one clinical trial at a time. Your expertise and dedication can help us bring hope and healing to patients worldwide.

We are an equal opportunity employer that welcomes and encourages diversity in the workplace. We do not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.